128 related articles for article (PubMed ID: 12788094)
21. E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase epsilon B-subunit gene POLE2.
Huang D; Jokela M; Tuusa J; Skog S; Poikonen K; Syväoja JE
Nucleic Acids Res; 2001 Jul; 29(13):2810-21. PubMed ID: 11433027
[TBL] [Abstract][Full Text] [Related]
22. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
Majello B; De Luca P; Suske G; Lania L
Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.
Lin SY; Black AR; Kostic D; Pajovic S; Hoover CN; Azizkhan JC
Mol Cell Biol; 1996 Apr; 16(4):1668-75. PubMed ID: 8657142
[TBL] [Abstract][Full Text] [Related]
25. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis.
Boutillier AL; Trinh E; Loeffler JP
J Neurochem; 2003 Feb; 84(4):814-28. PubMed ID: 12562525
[TBL] [Abstract][Full Text] [Related]
26. Transcription from TATA-less promoters: dihydrofolate reductase as a model.
Azizkhan JC; Jensen DE; Pierce AJ; Wade M
Crit Rev Eukaryot Gene Expr; 1993; 3(4):229-54. PubMed ID: 8286846
[TBL] [Abstract][Full Text] [Related]
27. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.
Blume SW; Snyder RC; Ray R; Thomas S; Koller CA; Miller DM
J Clin Invest; 1991 Nov; 88(5):1613-21. PubMed ID: 1834700
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the dihydrofolate reductase gene.
Slansky JE; Farnham PJ
Bioessays; 1996 Jan; 18(1):55-62. PubMed ID: 8593164
[TBL] [Abstract][Full Text] [Related]
29. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo.
Blake MC; Azizkhan JC
Mol Cell Biol; 1989 Nov; 9(11):4994-5002. PubMed ID: 2601705
[TBL] [Abstract][Full Text] [Related]
31. Autoregulation of mouse histone deacetylase 1 expression.
Schuettengruber B; Simboeck E; Khier H; Seiser C
Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
[TBL] [Abstract][Full Text] [Related]
32. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression.
Chiang SY; Azizkhan JC; Beerman TA
Biochemistry; 1998 Mar; 37(9):3109-15. PubMed ID: 9485464
[TBL] [Abstract][Full Text] [Related]
33. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
35. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection.
Wade M; Kowalik TF; Mudryj M; Huang ES; Azizkhan JC
Mol Cell Biol; 1992 Oct; 12(10):4364-74. PubMed ID: 1328853
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor Sp1 recognizes a DNA sequence in the mouse dihydrofolate reductase promoter.
Dynan WS; Sazer S; Tjian R; Schimke RT
Nature; 1986 Jan 16-22; 319(6050):246-8. PubMed ID: 3945313
[TBL] [Abstract][Full Text] [Related]
37. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
[TBL] [Abstract][Full Text] [Related]
38. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
39. Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors.
Joshi B; Ordonez-Ercan D; Dasgupta P; Chellappan S
Oncogene; 2005 Mar; 24(13):2204-17. PubMed ID: 15735762
[TBL] [Abstract][Full Text] [Related]
40. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene.
Wade M; Blake MC; Jambou RC; Helin K; Harlow E; Azizkhan JC
J Biol Chem; 1995 Apr; 270(17):9783-91. PubMed ID: 7730357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
